Frequent genes in rare diseases: panel‐based next generation sequencing to disclose causal mutations in hereditary neuropathies
Open Access
- 13 September 2017
- journal article
- research article
- Published by Wiley in Journal of Neurochemistry
- Vol. 143 (5), 507-522
- https://doi.org/10.1111/jnc.14217
Abstract
Hereditary neuropathies comprise a wide variety of chronic diseases associated to more than 80 genes identified to date. We herein examined 612 index patients with either a Charcot‐Marie‐Tooth phenotype, hereditary sensory neuropathy, familial amyloid neuropathy, or small fiber neuropathy using a customized multigene panel based on the next generation sequencing technique. In 121 cases (19.8%), we identified at least one putative pathogenic mutation. Of these, 54.4% showed an autosomal dominant, 33.9% an autosomal recessive, and 11.6% an X‐linked inheritance. The most frequently affected genes were PMP22 (16.4%), GJB1 (10.7%), MPZ, and SH3TC2 (both 9.9%), and MFN2 (8.3%). We further detected likely or known pathogenic variants in HINT1, HSPB1, NEFL, PRX, IGHMBP2, NDRG1, TTR, EGR2, FIG4, GDAP1, LMNA, LRSAM1, POLG, TRPV4, AARS, BIC2, DHTKD1, FGD4, HK1, INF2, KIF5A, PDK3, REEP1, SBF1, SBF2, SCN9A, and SPTLC2 with a declining frequency. Thirty‐four novel variants were considered likely pathogenic not having previously been described in association with any disorder in the literature. In one patient, two homozygous mutations in HK1 were detected in the multigene panel, but not by whole exome sequencing. A novel missense mutation in KIF5A was considered pathogenic because of the highly compatible phenotype. In one patient, the plasma sphingolipid profile could functionally prove the pathogenicity of a mutation in SPTLC2. One pathogenic mutation in MPZ was identified after being previously missed by Sanger sequencing. We conclude that panel based next generation sequencing is a useful, time‐ and cost‐effective approach to assist clinicians in identifying the correct diagnosis and enable causative treatment considerations.Keywords
Funding Information
- Swiss National Foundation SNF (31003A_153390/1)
- Rare Disease Initiative Zurich
This publication has 53 references indexed in Scilit:
- HSAN1 mutations in serine palmitoyltransferase reveal a close structure–function–phenotype relationshipHuman Molecular Genetics, 2015
- Application of targeted multi-gene panel testing for the diagnosis of inherited peripheral neuropathy provides a high diagnostic yield with unexpected phenotype-genotype variabilityBMC Medical Genetics, 2015
- The allelic spectrum of Charcot–Marie–Tooth disease in over 17,000 individuals with neuropathyMolecular Genetics & Genomic Medicine, 2014
- Rare-disease genetics in the era of next-generation sequencing: discovery to translationNature Reviews Genetics, 2013
- Tafamidis for transthyretin familial amyloid polyneuropathyNeurology, 2012
- Mutations in the motor and stalk domains of KIF5A in spastic paraplegia type 10 and in axonal Charcot–Marie–Tooth type 2Clinical Genetics, 2011
- Clinical and in silico evidence for and against pathogenicity of 11 new mutations in the MPZ geneClinical Genetics, 2010
- Genetic diagnosis by whole exome capture and massively parallel DNA sequencingProceedings of the National Academy of Sciences of the United States of America, 2009
- Mutation nomenclature extensions and suggestions to describe complex mutations: A discussionHuman Mutation, 1999
- A PECULIAR FORM OF PERIPHERAL NEUROPATHYBrain, 1952